The glycation of albumin: Structural and functional impacts

Biochimie

Volumn 93, Issue 4, 2011, Pages 645-658

  Rondeau, Philippe ^a   Bourdon, Emmanuel ^a  

^a UNIVERSITÉ DE LA RÉUNION   (France)

Author keywords

Glycated albumin; Glycation; Glycoxidation; Oxidative stress; Serum albumin

Indexed keywords

ALBUMIN; AMIDE; BILIRUBIN; CAPTOPRIL; COPPER; DANSYL AMIDE; DANSYLPROLINE; DANSYLSARCOSINE; DIAZEPAM; FATTY ACID; FLUFENAMIC ACID; FUROSEMIDE; IBUPROFEN; IRON; MONOCLONAL ANTIBODY; NAPROXEN; PHENYLBUTAZONE; PROLINE; SALICYLIC ACID; SARCOSINE; THIOCTIC ACID; TRYPTOPHAN; UNCLASSIFIED DRUG; WARFARIN;

ANTIOXIDANT ACTIVITY; CELL FUNCTION; DIABETES MELLITUS; DISEASE MARKER; GLYCATION; HUMAN; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

ANTIOXIDANTS; DIABETES MELLITUS; DISEASE; GLUCOSE; GLYCOSYLATION; HUMANS; HYPERGLYCEMIA; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE OXYGEN SPECIES; SERUM ALBUMIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79952446703     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.12.003     Document Type: Review

References (225)

1. T.W. Evans Albumin as a drugbiological effects of albumin unrelated to oncotic pressure Aliment Pharmacol. Ther. 16 2002 6 11 (Pubitemid 41759557)
2. T.J. Peters All about Albumin - Biochemistry, Genetics, and Medical Applications 1996 Academic Press San Diego
3. J.F. Foster Albumin Structure, Function and Uses 1977 Pergamon Oxford 53-84 p
4. G. Scatchard, A.C. Batchelder, and A. Brown Chemical, clinical, and immunological studies on the products of human plasma fractionation. Vi. The osmotic pressure of plasma and of serum albumin J. Clin. Invest. 23 1944 458 464
5. J. Figge, T.H. Rossing, and V. Fencl The role of serum proteins in acid-base equilibria J. Lab. Clin. Med. 117 1991 453 467
6. T.A. Waldmann Albumin Structure, Function and Uses 1977 Pergamon Press New York 255-273 p
7. M. Wood Plasma drug binding: implications for anesthesiologists Anesth. Analg. 65 1986 786 804 (Pubitemid 16085798)
8. F. Kratz Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles J. Control Release 132 2008 171 183
9. G. Sudlow, D.J. Birkett, and D.N. Wade Further characterization of specific drug binding sites on human serum albumin Mol. Pharmacol. 12 1976 1052 1061
10. D.C. Carter, and J.X. Ho Structure of serum albumin Adv. Protein Chem. 45 1994 153 203 (Pubitemid 24139888)
11. G.J. Quinlan, G.S. Martin, and T.W. Evans Albumin: biochemical properties and therapeutic potential Hepatology 41 2005 1211 1219 (Pubitemid 40770271)
12. G. Weber Energetics of ligand binding to proteins Adv. Protein Chem. 29 1975 1 83
13. P. Daneshgar, A.A. Moosavi-Movahedi, P. Norouzi, M.R. Ganjali, A. Madadkar-Sobhani, and A.A. Saboury Molecular interaction of human serum albumin with paracetamol: spectroscopic and molecular modeling studies Int. J. Biol. Macromol. 45 2009 129 134
14. I. Petitpas, A.A. Bhattacharya, S. Twine, M. East, and S. Curry Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I J. Biol. Chem. 276 2001 22804 22809
15. Y. Qiu, A.L. Burlingame, and L.Z. Benet Mechanisms for covalent binding of benoxaprofen glucuronide to human serum albumin. Studies By tandem mass spectrometry Drug Metab. Dispos. 26 1998 246 256 (Pubitemid 28182401)
16. K. Oettl, and R.E. Stauber Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties Br. J. Pharmacol. 151 2007 580 590 (Pubitemid 47016287)
17. T. Abe, T. Abe, S. Ageta, T. Kakuta, N. Suzuki, H. Hirata, M. Shouno, H. Saio, and T. Akizawa A new method for removal of albumin-binding uremic toxins: efficacy of an albumin-dialysate Therap. Apheresis 5 2001 58 63 (Pubitemid 32193256)
18. T. Sakai, A. Takadate, and M. Otagiri Characterization of binding site of uremic toxins on human serum albumin Biol. Pharm. Bull. 18 1995 1755 1761 (Pubitemid 26012996)
19. P.J. Thornalley, M. Argirova, N. Ahmed, V.M. Mann, O. Argirov, and A. Dawnay Mass spectrometric monitoring of albumin in uremia Kidney Int. 58 2000 2228 2234
20. E. Bourdon, and D. Blache The importance of proteins in defense against oxidation Antioxid. Redox Signal 3 2001 293 311 (Pubitemid 32473344)
21. B. Halliwell Albumin - an important extracellular antioxidant? Biochem. Pharmacol. 37 1988 569 571
22. B. Halliwell, and J.M. Gutteridge The antioxidants of human extracellular fluids Arch. Biochem. Biophys. 280 1990 1 8 (Pubitemid 20196526)
23. M. Roche, P. Rondeau, N.R. Singh, E. Tarnus, and E. Bourdon The antioxidant properties of serum albumin FEBS Lett. 582 2008 1783 1787
24. S. Carballal, B. Alvarez, L. Turell, H. Botti, B.A. Freeman, and R. Radi Sulfenic acid in human serum albumin Amino Acids 32 2007 543 551 (Pubitemid 46790936)
25. J.M. Gutteridge Antioxidant properties of the proteins caeruloplasmin, albumin and transferrin. A study of their activity in serum and synovial fluid from patients with rheumatoid arthritis Biochim. Biophys. Acta 869 1986 119 127 (Pubitemid 16212916)
26. H. Lee, and I.H. Kim Thioredoxin-linked lipid hydroperoxide peroxidase activity of human serum albumin in the presence of palmitoyl coenzyme A Free Radic. Biol. Med. 30 2001 327 333 (Pubitemid 32126452)
27. U. Kragh-Hansen, V.T. Chuang, and M. Otagiri Practical aspects of the ligand-binding and enzymatic properties of human serum albumin Biol. Pharm. Bull. 25 2002 695 704 (Pubitemid 40036701)
28. R.L. Levine, B.S. Berlett, J. Moskovitz, L. Mosoni, and E.R. Stadtman Methionine residues may protect proteins from critical oxidative damage Mech. Ageing Dev. 107 1999 323 332 (Pubitemid 29210232)
29. R.L. Levine, L. Mosoni, B.S. Berlett, and E.R. Stadtman Methionine residues as endogenous antioxidants in proteins Proc. Natl. Acad. Sci. U.S.A. 93 1996 15036 15040 (Pubitemid 27009547)
30. H. Rubbo, S. Parthasarathy, S. Barnes, M. Kirk, B. Kalyanaraman, and B.A. Freeman Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives Arch. Biochem. Biophys. 324 1995 15 25
31. H.S. Bhonsle, S.K. Singh, G. Srivastava, R. Boppana, and M.J. Kulkarni Albumin competitively inhibits glycation of less abundant proteins Protein Pept. Lett. 15 2008 663 667
32. M.E. Szapacs, J.N. Riggins, L.J. Zimmerman, and D.C. Liebler Covalent adduction of human serum albumin by 4-hydroxy-2-nonenal: kinetic analysis of competing alkylation reactions Biochemistry 45 2006 10521 10528 (Pubitemid 44320468)
33. G. Aldini, L. Gamberoni, M. Orioli, G. Beretta, L. Regazzoni, R. Maffei Facino, and M. Carini Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxy-trans-2-nonenal J. Mass Spectrom. 41 2006 1149 1161 (Pubitemid 44454168)
34. A.S. Charonis, L.A. Reger, J.E. Dege, K. Kouzi-Koliakos, L.T. Furcht, R.M. Wohlhueter, and E.C. Tsilibary Laminin alterations after in vitro nonenzymatic glycosylation Diabetes 39 1990 807 814 (Pubitemid 20211429)
35. H.J. Federoff, D. Lawrence, and M. Brownlee Nonenzymatic glycosylation of laminin and the laminin peptide CIKVAVS inhibits neurite outgrowth Diabetes 42 1993 509 513 (Pubitemid 23097180)
36. J.W. Hartog, A.A. Voors, S.J. Bakker, A.J. Smit, and D.J. van Veldhuisen Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications Eur. J. Heart Fail 9 2007 1146 1155 (Pubitemid 350138497)
37. P. Ulrich, and A. Cerami Protein glycation, diabetes, and aging Recent Prog. Horm. Res. 56 2001 1 21
38. P.J. Thornalley The clinical significance of glycation Clin. Lab. 5-6 1999 263 273 (Pubitemid 29253774)
39. M.P. Cohen Intervention strategies to prevent pathogenetic effects of glycated albumin Arch. Biochem. Biophys. 419 2003 25 30 (Pubitemid 37272157)
40. M.P. Cohen, E. Shea, S. Chen, and C.W. Shearman Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells J. Lab. Clin. Med. 141 2003 242 249 (Pubitemid 36432924)
41. N. Ahmed, O.K. Argirov, H.S. Minhas, C.A. Cordeiro, and P.J. Thornalley Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N- hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin Biochem. J. 364 2002 1 14 (Pubitemid 34538940)
42. K. Biemel, O. Reihl, J. Conrad, and M. Lederer Formation pathways for lysine-arginine cross-links derived from hexoses and pentoses by Maillard processes J. Biol. Chem. 276 2001 23405 23412
43. K. Nakamura, Y. Nakazawa, and K. Ienaga Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose Biochem. Biophys. Res. Commun. 6 1997 227 230 (Pubitemid 27211953)
44. S.R. Thorpe, and J.W. Baynes Maillard reaction products in tissue proteins: new products and new perspectives Amino Acids 25 2003 275 281 (Pubitemid 38041265)
45. T.J. Lyons Glycation and oxidation: a role in the pathogenesis of atherosclerosis Am. J. Cardiol. 71 1993 26B 31B (Pubitemid 23072403)
46. A.I. Ledesma-Osuna, G. Ramos-Clamont, and L. Vazquez-Moreno Characterization of bovine serum albumin glycated with glucose, galactose and lactose Acta Biochim. Pol. 55 2008 491 497
47. H. Böhles, J. Schädle, W. Endres, Y.S. Shin, F. Kollmann, S.W. Bender, and K. Kruse Increased concentrations of HbAlab in hereditary fructose intolerance and galactosemia Padiatr. Padol. 22 1987 25 31
48. P.S. Devamanoharan, A.H. Ali, and S.D. Varma Non-enzymatic glycation of lens proteins and haemoglobin-inhibition by pyruvate: an in-vivo study Diabet. Obes. Metabol. 1 1999 159 164
49. M. Otsyula, M.S. King, T.G. Ketcham, R.A. Sanders, and J.B. Watkins Oxidative stress in rats after 60 days of hypergalactosemia or hyperglycemia Int. J. Toxicol. 22 2003 423 427 (Pubitemid 38095103)
50. J.C. Urbanowski, M.A. Cohenford, and J.A. Dain Nonenzymatic galactosylation of human serum albumin. In vitro preparation J. Biol. Chem. 257 1982 111 115 (Pubitemid 12109761)
51. P.J. Thornalley, A. Langborg, and H.S. Minhas Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose Biochem. J. 344 Pt 1 1999 109 116
52. S.A. Phillips, and P.J. Thornalley Formation of methylglyoxal and d-lactate in human red blood cells in vitro Biochem. Soc. Trans. 21 1993 163S (Pubitemid 23167831)
53. M. Ray, and S. Ray Aminoacetone oxidase from goat liver. Formation of methylglyoxal from aminoacetone J. Biol. Chem. 262 1987 5974 5977
54. G. Poli, M.U. Dianzani, K.H. Cheeseman, T.F. Slater, J. Lang, and H. Esterbauer Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions Biochem. J. 227 1985 629 638 (Pubitemid 15067738)
55. F.W. Chaplen, W.E. Fahl, and D.C. Cameron Detection of methylglyoxal as a degradation product of DNA and nucleic acid components treated with strong acid Anal. Biochem. 236 1996 262 269 (Pubitemid 26136104)
56. H.F. Bunn, and P.J. Higgins Reaction of monosaccharides with proteins: possible evolutionary significance Science 213 1981 222 224 (Pubitemid 11060569)
57. J.V. Valencia, S.C. Weldon, D. Quinn, G.H. Kiers, J. DeGroot, J.M. TeKoppele, and T.E. Hughes Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics Anal. Biochem. 324 2004 68 78 (Pubitemid 37491125)
58. N. Sattarahmady, A.A. Moosavi-Movahedi, M. Habibi-Rezaei, S. Ahmadian, A.A. Saboury, H. Heli, and N. Sheibani Detergency effects of nanofibrillar amyloid formation on glycation of human serum albumin Carbohydr. Res. 343 2008 2229 2234
59. N. Shaklai, R.L. Garlick, and H.F. Bunn Nonenzymatic glycosylation of human serum albumin alters its conformation and function J. Biol. Chem. 259 1984 3812 3817 (Pubitemid 14170093)
60. E. Bourdon, N. Loreau, and D. Blache Glucose and free radicals impair the antioxidant properties of serum albumin FASEB J. 13 1999 233 244 (Pubitemid 29072400)
61. M. Inaba, S. Okuno, Y. Kumeda, S. Yamada, Y. Imanishi, T. Tabata, M. Okamura, S. Okada, T. Yamakawa, E. Ishimura, Y. Nishizawa, and C.K.D.E.R.G. and the Osaka Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection J. Am. Soc. Nephrol. 18 2007 896 903 (Pubitemid 46434506)
62. L. Lu, L.J. Pu, X.W. Xu, Q. Zhang, R.Y. Zhang, J.S. Zhang, J. Hu, Z.K. Yang, A.K. Lu, F.H. Ding, J. Shen, Q.J. Chen, S. Lou, D.H. Fang, and W.F. Shen Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus Clin. Biochem. 40 2007 810 816 (Pubitemid 46961968)
63. N. Miyamoto, N. Shirakawa, Y. Kuroda, F. Abe, and K. Shima Serum levels of glycated albumin in non-diabetic and insulin-dependent diabetic children Acta Paediatr. Jpn. 32 1990 249 256 (Pubitemid 20281028)
64. R. Paroni, F. Ceriotti, R. Galanello, G. Battista Leoni, A. Panico, E. Scurati, R. Paleari, L. Chemello, V. Quaino, L. Scaldaferri, A. Lapolla, and A. Mosca Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma Clin. Biochem. 40 2007 1398 1405 (Pubitemid 350151420)
65. V. Viswanathan, S. Kumpatla, P. Tilak, and P. Muthukumaran Levels of glycated albumin at different stages of diabetic nephropathy in India Int. J. Diabet. Metabol. 17 2009 77 80
66. K. Yoshiuchi, M. Matsuhisa, N. Katakami, Y. Nakatani, K. Sakamoto, T. Matsuoka, Y. Umayahara, K. Kosugi, H. Kaneto, Y. Yamasaki, and M. Hori Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes Endocr. J. 55 2008 503 507 (Pubitemid 351949744)
67. R. Kisugi, T. Kouzuma, T. Yamamoto, S. Akizuki, H. Miyamoto, Y. Someya, J. Yokoyama, I. Abe, N. Hirai, and A. Ohnishi Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin Clin. Chim. Acta 382 2007 59 64 (Pubitemid 46782738)
68. N. Ahmed, and P.J. Thornalley Advanced glycation endproducts: what is their relevance to diabetic complications? Diabet. Obes. Metab. 9 2007 233 245 (Pubitemid 46502041)
69. G. Desch Aspects biochimiques et analytiques du diagnostic et de la surveillance du diabte Médecine Nucléaire-Imagerie fonctionnelle et métabolique 25 2001 61 72 (Pubitemid 32895715)
70. R. Dolhofer, and O.H. Wieland Improvement of the thiobarbituric acid assay for serum glycosylprotein determination Clin. Chim. Acta 112 1981 197 204 (Pubitemid 11156255)
71. E. Elder, and L. Kennedy Rapid, accurate colorimetric assay of non-enzymatically glycosylated serum proteins Diabetologia 24 1983 70 71 (Pubitemid 13167164)
72. J.R. Baker, P.A. Metcalf, R.N. Johnson, D. Newman, and P. Rietz Use of protein-based standards in automated colorimetric determinations of fructosamine in serum Clin. Chem. 31 1985 1550 1554 (Pubitemid 16011848)
73. S. Mashiba, K. Uchida, S. Okuda, and S. Tomita Measurement of glycated albumin by the nitroblue tetrazolium colorimetric method Clin. Chim. Acta 212 1992 3 15
74. M. Vanhaeverbeek, D. Brohee, A. Lefevre, P. Piro, B. Kennes, and P. Neve Thiobarbiturate and fructosamine assays: significance and interest of the borohydride blank Acta Diabetol. 31 1994 43 46 (Pubitemid 24140478)
75. J. Davidson Measuring carbohydrates, lipids and proteins J.K. Davidson, Clinical Diabetes Mellitus: A Problem-oriented Approach 1986 Thieme Inc. New York, NY 198 199
76. W. Liu, and R. He Effect of thiols on fructosamine assay Biochem. Mol. Biol. Int. 42 1997 277 283 (Pubitemid 28297675)
77. Y.J. Xu, X.Q. Wu, W. Liu, X.H. Lin, J.W. Chen, and R.Q. He A convenient assay of glycoserum by nitroblue tetrazolium with iodoacetamide Clin. Chim. Acta 325 2002 127 131 (Pubitemid 35279634)
78. A.S. Acharya, and J.M. Manning Amadori rearrangement of glyceraldehyde-hemoglobin Schiff base adducts. A new procedure for the determination of ketoamine adducts in proteins J. Biol. Chem. 255 1980 7218 7224
79. G.M. Ghiggeri, G. Candiano, G. Delfino, C. Queirolo, G. Pallavicini, and F. Ginevri Characterisation of the phenylhydrazone derivatives of "glycated albumin" purified from diabetic sera Carbohydr. Res. 153 1986 314 317
80. D.A. Armbruster Fructosamine: structure, analysis, and clinical usefulness Clin. Chem. 33 1987 2153 2163
81. T. Kouzuma, Y. Uemastu, T. Usami, and S. Imamura Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method Clin. Chim. Acta 346 2004 135 143 (Pubitemid 38901044)
82. K. Shima, N. Ito, F. Abe, M. Hirota, M. Yano, Y. Yamamoto, T. Uchida, and K. Noguchi High-performance liquid chromatographic assay of serum glycated albumin Diabetologia 31 1988 627 631
83. E. Schleicher, and O.H. Wieland Specific quantitation by HPLC of protein (lysine) bound glucose in human serum albumin and other glycosylated proteins J. Clin. Chem. Clin. Biochem. 19 1981 81 87 (Pubitemid 11135965)
84. O.S. Barnaby, R.L. Cerny, W. Clarke, and D.S. Hage Comparison of modification sites formed on human serum albumin at various stages of glycation Clin. Chim. Acta 412 2011 277 285
85. M.P. Morais, J.D. Mackay, S.K. Bhamra, J.G. Buchanan, T.D. James, J.S. Fossey, and J.M. van den Elsen Analysis of protein glycation using phenylboronate acrylamide gel electrophoresis Proteomics 10 2009 48 58
86. K. Ikeda, Y. Sakamoto, Y. Kawasaki, T. Miyake, K. Tanaka, T. Urata, Y. Katayama, S. Ueda, and S. Horiuchi Determination of glycated albumin by enzyme-linked boronate immunoassay (ELBIA) Clin. Chem. 44 1998 256 263 (Pubitemid 28087721)
87. Y. Ohe, M. Matsuura, Y. Nakajima, S. Shin, F. Hashimoto, M. Hirota, and K. Shima Radioimmunoassay of glycosylated albumin with monoclonal antibody to glucitol-lysine Clin. Chim. Acta 169 1987 229 238 (Pubitemid 18007047)
88. Z. Makita, H. Vlassara, A. Cerami, and R. Bucala Immunochemical detection of advanced glycosylation end products in vivo J. Biol. Chem. 267 1992 5133 5138
89. J.R. Brown Serum Albumin:Amino Acid Sequence 1977 Pergamon Press Oxford
90. P. Rondeau, N. Singh, H. Caillens, and E. Bourdon Oxidative stresses induced by glycated human or bovine serum albumins on human monocytes Free Radic. Biol. Med. 45 2008 799 812
91. A. Schmitt, J. Gasic-Milenkovic, and J. Schmitt Characterization of advanced glycation end products: mass changes in correlation to side chain modifications Anal. Biochem. 346 2005 101 106 (Pubitemid 41456631)
92. R.L. Garlick, and J.S. Mazer The principal site of nonenzymatic glycosylation of human serum albumin in vivo J. Biol. Chem. 258 1983 6142 6146 (Pubitemid 13106789)
93. N. Iberg, and R. Fluckiger Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites J. Biol. Chem. 261 1986 13542 13545 (Pubitemid 17196372)
94. S.A. Marashi, S. Safarian, and A.A. Moosavi-Movahedi Why major nonenzymatic glycation sites of human serum albumin are preferred to other residues? Med. Hypotheses 64 2005 881 (Pubitemid 40203082)
95. A. Lapolla, D. Fedele, R. Reitano, N.C. Arico, R. Seraglia, P. Traldi, E. Marotta, and R. Tonani Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides J. Am. Soc. Mass Spectrom. 15 2004 496 509 (Pubitemid 38407135)
96. C. Wa, R.L. Cerny, W.A. Clarke, and D.S. Hage Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Clin. Chim. Acta 385 2007 48 60 (Pubitemid 47374666)
97. J.W. Baynes, S.R. Thorpe, and M.H. Murtiashaw Nonenzymatic glucosylation of lysine residues in albumin Methods Enzymol. 106 1984 88 98 (Pubitemid 14079122)
98. N. Mori, and J.M. Manning Studies on the Amadori rearrangement in a model system: chromatographic isolation of intermediates and product Anal. Biochem. 152 1986 396 401
99. A. Frolov, and R. Hoffmann Identification and relative quantification of specific glycation sites in human serum albumin Anal. Bioanal. Chem. 397 2010 2349 2356
100. M.P. Cohen Diabetes and Protein Glycation 1986 Springer-Verlag Inc. New York 144 p
101. D.A. Robb, O.S. Olufemi, D.A. Williams, and J.M. Midgley Identification of glycation at the N-terminus of albumin by gas chromatography-mass spectrometry Biochem. J. 261 1989 871 878 (Pubitemid 19209528)
102. D.J. Hinton, and J.M. Ames Site specificity of glycation and carboxymethylation of bovine serum albumin by fructose Amino Acids 30 2006 425 434
103. Y. Wada Primary sequence and glycation at lysine-548 of bovine serum albumin J. Mass Spectros. 31 1996 263 266 (Pubitemid 26084294)
104. F. Leslie, C. Muhammad, B. Tiffany, and C. Menashi In-vitro galactation of human serum albumin: analysis of the protein's galactation sites by mass spectrometry Anal. Biochem. 2010
105. N. Ahmed, D. Dobler, M. Dean, and P.J. Thornalley Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity J. Biol. Chem. 280 2005 5724 5732 (Pubitemid 40280052)
106. N. Ahmed, and P.J. Thornalley Peptide mapping of human serum albumin modified minimally by methylglyoxal in vitro and in vivo Ann. N.Y. Acad. Sci. 1043 2005 260 266 (Pubitemid 41123913)
107. K. Iijima, D. Fujimoto, and S. Irie Amount of N(omega)-(Carboxymethyl) arginine generated in collagen and bovine serum albumin during glycation reactions is significantly different Connect Tissue Res. 48 2007 271 276 (Pubitemid 47456935)
108. K. Mera, Y. Fujiwara, M. Otagiri, N. Sakata, and R. Nagai Immunological detection of N omega-(Carboxymethyl)arginine by a specific antibody Ann. N.Y. Acad. Sci. 1126 2008 155 157 (Pubitemid 351589263)
109. J. Zeng, and M.J. Davies Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins Chem. Res. Toxicol. 18 2005 1232 1241 (Pubitemid 41170247)
110. A.A. Mostafa, E.W. Randell, S.C. Vasdev, V.D. Gill, Y. Han, V. Gadag, A.A. Raouf, and H. El Said Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes Mol. Cell Biochem. 302 2007 35 42 (Pubitemid 47202318)
111. J. Acimovic, B. Stanimirovic, and L. Mandic The role of the thiol group in protein modification with methylglyoxal J. Serbian Chem. Soc. 74 2009 867 883
112. H. Sakamoto, T. Mashima, K. Yamamoto, and T. Tsuruo Modulation of heat-shock protein 27 (Hsp27) anti-apoptotic activity by methylglyoxal modification J. Biol. Chem. 277 2002 45770 45775 (Pubitemid 35417554)
113. P.J. Thornalley Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs Cell. Mol. Biol. 44 1998 1013 1023
114. P.J. Thornalley, S. Battah, N. Ahmed, N. Karachalias, S. Agalou, R. Babael-Jadidi, and A. Dawnay Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem massspectrometry Biochem. J. 375 2003 581 592 (Pubitemid 37433506)
115. P.J. Coussons, J. Jacoby, A. McKay, S.M. Kelly, N.C. Price, and J.V. Hunt Glucose modification of human serum albumin: a structural study Free Radic. Biol. Med. 22 1997 1217 1227 (Pubitemid 27171964)
116. P. Rondeau, G. Navarra, F. Cacciabaudo, M. Leone, E. Bourdon, and V. Militello Thermal aggregation of glycated bovine serum albumin Biochim. Biophys. Acta 1804 2010 789 798
117. N. Sattarahmady, A.A. Moosavi-Movahedi, F. Ahmad, G.H. Hakimelahi, M. Habibi-Rezaei, A.A. Saboury, and N. Sheibani Formation of the molten globule-like state during prolonged glycation of human serum albumin Biochim. Biophys. Acta 1770 2007 933 942 (Pubitemid 46628994)
118. J. Chamani, A.A. Moosavi-Movahedi, O. Rajabi, M. Gharanfoli, M. Momen-Heravi, G.H. Hakimelahi, A. Neamati-Baghsiah, and A.R. Varasteh Cooperative alpha-helix formation of beta-lactoglobulin induced by sodium n-alkyl sulfates J. Colloid Interface Sci. 293 2006 52 60 (Pubitemid 41635334)
119. H. Zoellner, J.Y. Hou, T. Hochgrebe, A. Poljak, M.W. Duncan, J. Golding, T. Henderson, and G. Lynch Fluorometric and mass spectrometric analysis of nonenzymatic glycosylated albumin Biochem. Biophys. Res. Commun. 284 2001 83 89 (Pubitemid 32924312)
120. D.L. Mendez, R.A. Jensen, L.A. McElroy, J.M. Pena, and R.M. Esquerra The effect of non-enzymatic glycation on the unfolding of human serum albumin Arch. Biochem. Biophys. 444 2005 92 99 (Pubitemid 41728341)
121. M.W. Khan, Z. Rasheed, W.A. Khan, and R. Ali Biochemical, biophysical, and thermodynamic analysis of in vitro glycated human serum albumin Biochemistry (Mosc) 72 2007 146 152 (Pubitemid 46347479)
122. B. Bouma, L.M. Kroon-Batenburg, Y.P. Wu, B. Brunjes, G. Posthuma, O. Kranenburg, P.G. de Groot, E.E. Voest, and M.F. Gebbink Glycation induces formation of amyloid cross-beta structure in albumin J. Biol. Chem. 278 2003 41810 41819 (Pubitemid 37310441)
123. Y. Wei, L. Chen, J. Chen, L. Ge, and R.Q. He Rapid glycation with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells BMC Cell Biol. 10 2009 10
124. P. Rondeau, S. Armenta, H. Caillens, S. Chesne, and E. Bourdon Assessment of temperature effects on beta-aggregation of native and glycated albumin by FTIR spectroscopy and PAGE: relations between structural changes and antioxidant properties Arch. Biochem. Biophys. 460 2007 141 150 (Pubitemid 46505004)
125. S. Chesne, P. Rondeau, S. Armenta, and E. Bourdon Effects of oxidative modifications induced by the glycation of bovine serum albumin on its structure and on cultured adipose cells Biochimie 2006
126. P. Faure, L. Troncy, M. Lecomte, N. Wiernsperger, M. Lagarde, D. Ruggiero, and S. Halimi Albumin antioxidant capacity is modified by methylglyoxal Diabet. Metab. 31 2005 169 177 (Pubitemid 40577201)
127. A. Stolzing, R. Widmer, T. Jung, P. Voss, and T. Grune Degradation of glycated bovine serum albumin in microglial cells Free Radic. Biol. Med. 40 2006 1017 1027 (Pubitemid 43376011)
128. E. Bourdon, N. Loreau, L. Lagrost, and D. Blache Differential effects of cysteine and methionine residues in the antioxidant activity of human serum albumin Free Radic. Res. 39 2005 15 20 (Pubitemid 40309466)
129. J.P. Bohney, and R.C. Feldhoff Effects of nonenzymatic glycosylation and fatty acids on tryptophan binding to human serum albumin Biochem. Pharmacol. 43 1992 1829 1834
130. A. Barzegar, A.A. Moosavi-Movahedi, N. Sattarahmady, M.A. Hosseinpour-Faizi, M. Aminbakhsh, F. Ahmad, A.A. Saboury, M.R. Ganjali, and P. Norouzi Spectroscopic studies of the effects of glycation of human serum albumin on L-Trp binding Protein Pept. Lett. 14 2007 13 18 (Pubitemid 46046947)
131. N. Okabe, and N. Hashizume Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism Biol. Pharm. Bull. 17 1994 16 21 (Pubitemid 24056977)
132. K. Koizumi, C. Ikeda, M. Ito, J. Suzuki, T. Kinoshita, K. Yasukawa, and T. Hanai Influence of glycosylation on the drug binding of human serum albumin Biomed. Chromatogr. 12 1998 203 210 (Pubitemid 28297918)
133. K. Mera, K. Takeo, M. Izumi, T. Maruyama, R. Nagai, and M. Otagiri Effect of reactive-aldehydes on the modification and dysfunction of human serum albumin J. Pharm. Sci. 99 2009 1614 1625
134. K. Nakajou, H. Watanabe, U. Kragh-Hansen, T. Maruyama, and M. Otagiri The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants Biochim. Biophys. Acta 1623 2003 88 97 (Pubitemid 37315665)
135. M.D. Argirova, and B.J. Ortwerth Activation of protein-bound copper ions during early glycation: study on two proteins Arch. Biochem. Biophys. 420 2003 176 184 (Pubitemid 37393385)
136. J.W. Eaton, and M. Qian Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy Mol. Cell Biochem. 234-235 2002 135 142 (Pubitemid 34777850)
137. E. Yamazaki, M. Inagaki, O. Kurita, and T. Inoue Kinetics of fatty acid binding ability of glycated human serum albumin J. Biosci. 30 2005 475 481 (Pubitemid 41391361)
138. Y. Keita, W. Kratzer, W. Worner, and N. Rietbrock Effect of free fatty acids on the binding kinetics at the benzodiazepine binding site of glycated human serum albumin Int. J. Clin. Pharmacol. Ther. Toxicol. 31 1993 337 342 (Pubitemid 23223379)
139. W.B. Karp, M. Kinsley, S.B. Subramanyam, and A.F. Robertson Binding properties of glycosylated albumin and acetaldehyde albumin Alcohol Clin. Exp. Res. 9 1985 429 432 (Pubitemid 16245573)
140. W. Worner, S. Pfleiderer, W. Kratzer, and N. Rietbrock Non-enzymatic glycation of human serum albumin: influence on the binding kinetics of the benzodiazepine binding sites J. Clin. Chem. Clin. Biochem. 28 1990 527 531 (Pubitemid 20281866)
141. A.D. Mariee, and O. Al-Shabanah Protective ability and binding affinity of captopril towards serum albumin in an in vitro glycation model of diabetes mellitus J. Pharm. Biomed. Anal. 41 2006 571 575
142. M.H. Murtiashaw, and K.H. Winterhalter Non-enzymatic glycation of human albumin does not alter its palmitate binding Diabetologia 29 1986 366 370 (Pubitemid 16060895)
143. G. Suji, S.A. Khedkar, S.K. Singh, N. Kishore, E.C. Coutinho, V.M. Bhor, and S. Sivakami Binding of lipoic acid induces conformational change and appearance of a new binding site in methylglyoxal modified serum albumin Protein J. 27 2008 205 214
144. J. MacKichan Influence of protein binding and use of unbound (free) drug concentrations M. Burton, L. Shaw, J. Schentag, W. Evans, Applied Pharmacokinetics & Pharmacodynamics: Principles of Therapeutic Drug Monitoring 2006 Lippincott Williams & Wilkins 82 120
145. G. Kearns, S. Kemp, C. Turley, and D. Nelson Protein binding of phenytoin and lidocaine in pediatric patients with type I diabetes mellitus Dev. Pharmacol. Ther. 11 1988 14 23 (Pubitemid 18079443)
146. F. Ruiz-Cabello, and S. Erill Abnormal serum protein binding of acidic drugs in diabetes mellitus Clin. Pharmacol. Ther. 36 1984 691 695 (Pubitemid 15224675)
147. S. Erill, and R. Calva Post-translational changes of albumin as a cause of altered drug-plasma protein binding M.M.E.S. Drug-Protein Binding 1986 Praeger Publishers New-York 220 232
148. M. Brownlee The pathological implications of protein glycation Clin. Invest. Med. 18 1995 275 281 (Pubitemid 26004873)
149. S. Chen, M.P. Cohen, and F.N. Ziyadeh Amadori-glycated albumin in diabetic nephropathy: pathophysiologic connections Kidney Int. Suppl. 77 2000 S40 S44
150. M.P. Cohen, E. Hud, and V.Y. Wu Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin Kidney Int. 45 1994 1673 1679 (Pubitemid 24207503)
151. M.P. Cohen, N. Masson, E. Hud, F. Ziyadeh, D.C. Han, and R.S. Clements Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse Exp. Nephrol. 8 2000 135 143 (Pubitemid 30313589)
152. F.N. Ziyadeh, and M.P. Cohen Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy Mol. Cell Biochem. 125 1993 19 25 (Pubitemid 23298786)
153. N.A. Hasan Effects of trace elements on albumin and lipoprotein glycation in diabetic retinopathy Saudi Med. J. 30 2009 1263 1271
154. J.P. Doweiko, and B.R. Bistrian The effect of glycosylated albumin on platelet aggregation J. Parenter. Enteral. Nutr. 18 1994 516 520 (Pubitemid 24371081)
155. D.A. Rubenstein, and W. Yin Glycated albumin modulates platelet susceptibility to flow induced activation and aggregation Platelets 20 2009 206 215
156. H. Candiloros, S. Muller, O. Ziegler, M. Donner, and P. Drouin Role of albumin glycation on the erythrocyte aggregation: an in vitro study Diabet. Med. 13 1996 646 650 (Pubitemid 26232506)
157. C. Miele, A. Riboulet, M.A. Maitan, F. Oriente, C. Romano, P. Formisano, J. Giudicelli, F. Beguinot, and E. Van Obberghen Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced
158. H. Unoki, H. Bujo, S. Yamagishi, M. Takeuchi, T. Imaizumi, and Y. Saito Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes Diabet. Res. Clin. Pract. 76 2007 236 244 (Pubitemid 46400134)
159. H. Unoki, and S. Yamagishi Advanced glycation end products and insulin resistance Curr. Pharm. Des. 14 2008 987 989 (Pubitemid 351753287)
160. N.R. Singh, P. Rondeau, and E. Bourdon Identification of up-regulated low molecular weight proteins in human adipocytes treated with glycoxidized albumin Open Obes. J. 2 2010 110 115
161. N.R. Singh, P. Rondeau, L. Hoareau, and E. Bourdon Identification of preferential protein targets for carbonylation in human mature adipocytes treated with native or glycated albumin Free Radic. Res. 41 2007 1078 1088 (Pubitemid 47470845)
162. J.L. Wautier, C. Zoukourian, O. Chappey, M.P. Wautier, P.J. Guillausseau, R. Cao, O. Hori, D. Stern, and A.M. Schmidt Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats J. Clin. Invest. 97 1996 238 243
163. H.M. Lander, J.M. Tauras, J.S. Ogiste, O. Hori, R.A. Moss, and A.M. Schmidt Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress J. Biol. Chem. 272 1997 17810 17814 (Pubitemid 27311222)
164. S.D. Yan, A.M. Schmidt, G.M. Anderson, J. Zhang, J. Brett, Y.S. Zou, D. Pinsky, and D. Stern Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins J. Biol. Chem. 269 1994 9889 9897 (Pubitemid 24196599)
165. Y. Hattori, H. Kakishita, K. Akimoto, M. Matsumura, and K. Kasai Glycated serum albumin-induced vascular smooth muscle cell proliferation through activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by protein kinase C Biochem. Biophys. Res. Commun. 281 2001 891 896 (Pubitemid 32917814)
166. Y. Hattori, M. Suzuki, S. Hattori, and K. Kasai Vascular smooth muscle cell activation by glycated albumin (amadori adducts) Hypertension 39 2002 22 28 (Pubitemid 34098083)
167. X. Fan, R. Subramaniam, M.F. Weiss, and V.M. Monnier Methylglyoxal-bovine serum albumin stimulates tumor necrosis factor alpha secretion in RAW 264.7 cells through activation of mitogen-activating protein kinase, nuclear factor kappaB and intracellular reactive oxygen species formation Arch. Biochem. Biophys. 409 2003 274 286 (Pubitemid 36259595)
168. T. Naitoh, M. Kitahara, and N. Tsuruzoe Tumor necrosis factor-alpha is induced through phorbol ester - and glycated human albumin-dependent pathway in THP-1 cells Cell Signal 13 2001 331 334 (Pubitemid 32448950)
169. E.A. Abordo, and P.J. Thornalley Synthesis and secretion of tumour necrosis factor-alpha by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts Immunol. Lett. 58 1997 139 147 (Pubitemid 27382081)
170. J.C. Mamputu, and G. Renier Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants J. Leukoc. Biol. 75 2004 1062 1069 (Pubitemid 38720648)
171. H. Vlassara, H. Fuh, T. Donnelly, and M. Cybulsky Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits Mol. Med. 1 1995 447 456
172. H. Vlassara, Y.M. Li, F. Imani, D. Wojciechowicz, Z. Yang, F.T. Liu, and A. Cerami Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex Mol. Med. 1 1995 634 646
173. N. Ohgami, R. Nagai, M. Ikemoto, H. Arai, A. Miyazaki, H. Hakamata, S. Horiuchi, and H. Nakayama CD36, serves as a receptor for advanced glycation endproducts (AGE) J. Diabet. Complicat. 16 2002 56 59 (Pubitemid 34168502)
174. A. Kuniyasu, N. Ohgami, S. Hayashi, A. Miyazaki, S. Horiuchi, and H. Nakayama CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes FEBS Lett. 537 2003 85 90 (Pubitemid 36246681)
175. Y. Unno, M. Sakai, Y. Sakamoto, A. Kuniyasu, H. Nakayama, R. Nagai, and S. Horiuchi Advanced glycation end products-modified proteins and oxidized LDL mediate down-regulation of leptin in mouse adipocytes via CD36 Biochem. Biophys. Res. Commun. 325 2004 151 156 (Pubitemid 39441173)
176. C.G. Schalkwijk, M. Lieuw-a-Fa, V.W. van Hinsbergh, and C.D. Stehouwer Pathophysiological role of Amadori-glycated proteins in diabetic microangiopathy Semin. Vasc. Med. 2 2002 191 197
177. R. Brandt, C. Landmesser, L. Vogt, B. Hehmke, R. Hanschke, J. Kasbohm, K. Hartmann, B. Jäger, S. Krantz, and D. Michaelis Differential expression of fructosyllysine-specific receptors on monocytes and macrophages and possible pathophysiological significance Diabetologia 39 1996 1140 1147
178. S. Krantz, M. Lober, and L. Henschel The nonenzymatic glycation of proteins and nucleic acids, their importance for the development of diabetic complications, possible molecular basis of aging and autoimmunological processes Exp. Clin. Endocrinol. 88 1986 257 269 (Pubitemid 17221860)
179. R. Salazar, R. Brandt, and S. Krantz Expression of fructosyllysine receptors on human monocytes and monocyte-like cell lines Biochim. Biophys. Acta 1266 1995 57 63
180. V.Y. Wu, and M.P. Cohen Receptors specific for amadori-modified glycated albumin on murine endothelial cells Biochem. Biophys. Res. Commun. 198 1994 734 739 (Pubitemid 24178429)
181. V.Y. Wu, and M.P. Cohen Evidence for a ligand receptor system mediating the biologic effects of glycated albumin in glomerular mesangial cells Biochem. Biophys. Res. Commun. 207 1995 521 528
182. S. Krantz, R. Salazar, R. Brandt, J. Kellermann, and F. Lottspeich Purification and partial amino acid sequencing of a fructosyllysine-specific binding protein from cell membranes of the monocyte-like cell line U937 Biochim. Biophys. Acta 1266 1995 109 112
183. R. Salazar, R. Brandt, J. Kellermann, and S. Krantz Purification and characterization of a 200 kDa fructosyllysine-specific binding protein from cell membranes of U937 cells Glycoconj. J. 17 2000 713 716 (Pubitemid 32493949)
184. R. Brandt, M. Nawka, J. Kellermann, R. Salazar, D. Becher, and S. Krantz Nucleophosmin is a component of the fructoselysine-specific receptor in cell membranes of Mono Mac 6 and U937 monocyte-like cells Biochim. Biophys. Acta (BBA) General Subjects 1670 2004 132 136 (Pubitemid 38115857)
185. V.Y. Wu, C.W. Shearman, and M.P. Cohen Identification of calnexin as a binding protein for amadori-modified glycated albumin Biochem. Biophys. Res. Commun. 284 2001 602 606 (Pubitemid 32924771)
186. K. Higai, A. Shimamura, and K. Matsumoto Amadori-modified glycated albumin predominantly induces E-selectin expression on human umbilical vein endothelial cells through NADPH oxidase activation Clin. Chim. Acta 367 2006 137 143
187. Z. Turk, I. Kovacevic, V. Mrzljak, M. PraImagek, I. Bjelinski, and B. Benko Autoantibodies against advanced glycation endproducts (AGEs) in IDDM Diabet. Suppl. 1 1999 A431 48 (1999) 431
188. Z. Turk, V. Mrzljak, N. Turk, and Z. Metelko Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis Diabet. Nutr. Metab. 12 1999 413 417 (Pubitemid 30093557)
189. H. Nakayama, S. Taneda, S. Kuwajima, S. Aoki, Y. Kuroda, K. Misawa, and S. Nakagawa Production and characterization of antibodies to advanced glycation products on proteins Biochem. Biophys. Res. Commun. 162 1989 740 745 (Pubitemid 19200901)
190. Z. Turk, S. Ljubic, N. Turk, and B. Benko Detection of autoantibodies against advanced glycation endproducts and AGE-immune complexes in serum of patients with diabetes mellitus Clin. Chim. Acta 303 2001 105 115 (Pubitemid 32121812)
191. D. Vay, M. Vidali, G. Allochis, C. Cusaro, R. Rolla, E. Mottaran, G. Bellomo, and E. Albano Antibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients Diabetologia 43 2000 1385 1388
192. H. Nakayama, S. Taneda, T. Mitsuhashi, S. Kuwajima, S. Aoki, Y. Kuroda, K. Misawa, K. Yanagisawa, and S. Nakagawa Characterization of antibodies to advanced glycosylation end products on protein J. Immunol. Methods 140 1991 119 125
193. M.P. Cohen, K. Sharma, Y. Jin, E. Hud, V.Y. Wu, J. Tomaszewski, and F.N. Ziyadeh Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy J. Clin. Invest. 95 1995 2338 2345
194. M.P. Cohen, E. Hud, V.Y. Wu, and C.W. Shearman Amelioration of diabetes-associated abnormalities in the vitreous fluid by an inhibitor of albumin glycation Invest. Ophthalmol. Vis. Sci. 49 2008 5089 5093
195. E. Bonnardel-Phu, J.L. Wautier, A.M. Schmidt, C. Avila, and E. Vicaut Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo Diabetes 48 1999 2052 2058 (Pubitemid 29458371)
196. B.I. Hudson, T. Wendt, L.G. Bucciarelli, L.L. Rong, Y. Naka, S.F. Yan, and A.M. Schmidt Diabetic vascular disease: it's all the RAGE Antioxid. Redox Signal 7 2005 1588 1600 (Pubitemid 41767994)
197. B.S. Szwergold, S.K. Howell, and P.J. Beisswenger Nonenzymatic glycation/enzymatic deglycation: a novel hypothesis on the etiology of diabetic complications Int. Congr. Ser. 1245 2002 143 152
198. B. Szwergold, K. Taylor, S. Lal, B. Su, F. Kappler, and T. Brown Identification of a novel protein kinase activity specific for Amadori adducts on glycated proteins Diabetes 46 1997 108A
199. B.S. Szwergold, and P.J. Beisswenger Enzymatic deglycation - a new paradigm or an epiphenomenon? Biochem. Soc. Trans. 31 2003 1428 1432 (Pubitemid 38030993)
200. M.A. Hofmann, S. Drury, C.F. Fu, W. Qu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, M.F. Neurath, T. Slattery, D. Beach, J. McClary, M. Nagashima, J. Morser, D. Stern, and A.M. Schmidt RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889 901 (Pubitemid 29375048)
201. A. Kosaki, T. Hasegawa, T. Kimura, K. Iida, J. Hitomi, H. Matsubara, M. Mori, M. Okigaki, N. Toyoda, H. Masaki, M. Inoue-Shibata, M. Nishikawa, and T. Iwasaka Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes J. Clin. Endocrinol. Metab. 89 2004 5423 5428 (Pubitemid 39518420)
202. J.V. Valencia, M. Mone, J. Zhang, M. Weetall, F.P. Buxton, and T.E. Hughes Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA Diabetes 53 2004 743 751 (Pubitemid 38270645)
203. H.V. Roohk, and A.R. Zaidi A review of glycated albumin as an intermediate glycation index for controlling diabetes J. Diabet. Sci. Technol. 2 2008 1114 1121
204. J.F. Fitzgibbons, R.D. Koler, and R.T. Jones Red cell age-related changes of hemoglobins AIa+b and AIc in normal and diabetic subjects J. Clin. Invest. 58 1976 820 824
205. K. Hashimoto, T. Osugi, S. Noguchi, Y. Morimoto, K. Wasada, S. Imai, M. Waguri, R. Toyoda, T. Fujita, S. Kasayama, and M. Koga A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women Diabet. Care 33 2008 509 511
206. H. Ichikawa, Y. Nagake, M. Takahashi, H. Nakazono, K. Kawabata, K. Shikata, and H. Makino What is the best index of glycemic control in patients with diabetes mellitus on hemodialysis? Nippon Jinzo Gakkai Shi 38 1996 305 308 (Pubitemid 126496398)
207. S. Panzer, G. Kronik, K. Lechner, P. Bettelheim, E. Neumann, and R. Dudczak Glycosylated hemoglobins (GHb): an index of red cell survival Blood 59 1982 1348 1350 (Pubitemid 12074869)
208. L. Bry, P.C. Chen, and D.B. Sacks Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin Clin. Chem. 47 2001 153 163 (Pubitemid 32142912)
209. S.L. Jeffcoate Diabetes control and complications: the role of glycated haemoglobin, 25 years on Diabet. Med. 21 2004 657 665 (Pubitemid 38916208)
210. C.E. Guthrow, M.A. Morris, J.F. Day, S.R. Thorpe, and J.W. Baynes Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus Proc. Natl. Acad. Sci. U.S.A. 76 1979 4258 4261 (Pubitemid 9256541)
211. S.M. Kosecki, P.T. Rodgers, and M.B. Adams Glycemic monitoring in diabetics with sickle cell plus beta-thalassemia hemoglobinopathy Ann. Pharmacother. 39 2005 1557 1560 (Pubitemid 41197142)
212. A. Gugliucci Glycation as the glucose link to diabetic complications J. Am. Osteopath. Assoc. 100 2000 621 634
213. A. Okumura, Y. Mitamura, K. Namekata, K. Nakamura, C. Harada, and T. Harada Glycated albumin induces activation of activator protein-1 in retinal glial cells Jpn. J. Ophthalmol. 51 2007 236 237 (Pubitemid 46889503)
214. V.V. Shuvaev, I. Laffont, J.M. Serot, J. Fujii, N. Taniguchi, and G. Siest Increased protein glycation in cerebrospinal fluid of Alzheimer's disease Neurobiol. Aging 22 2001 397 402 (Pubitemid 32510910)
215. S. Yamada, M. Inaba, K. Shidara, S. Okada, M. Emoto, E. Ishimura, and Y. Nishizawa Association of glycated albumin, but not glycated hemoglobin, with peripheral vascular calcification in hemodialysis patients with type 2 diabetes Life Sci. 83 2008 516 519
216. Y. Kumeda, M. Inaba, S. Shoji, E. Ishimura, H. Inariba, S. Yabe, M. Okamura, and Y. Nishizawa Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes Clin. Endocrinol. (Oxf.) 69 2008 556 561
217. H. Nagayama, M. Inaba, R. Okabe, M. Emoto, E. Ishimura, S. Okazaki, and Y. Nishizawa Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test Biomed. Pharmacother. 63 2009 236 240
218. M. Koga, J. Murai, H. Saito, M. Mukai, S. Matsumoto, and S. Kasayama Glycated albumin levels are higher relative to glycated haemoglobin levels in gastrectomized subjects Ann. Clin. Biochem. 47 2009 39 43
219. M. Koga, S. Kasayama, H. Kanehara, and Y. Bando CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases Diabet. Res. Clin. Pract. 81 2008 258 262
220. M. Koga, J. Murai, H. Saito, S. Matsumoto, and S. Kasayama Effects of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects Diabet. Res. Clin. Pract. 84 2009 163 167
221. M. Koga, H. Saito, M. Mukai, M. Otsuki, and S. Kasayama Serum glycated albumin levels are influenced by smoking status, independent of plasma glucose levels Acta Diabetol. 46 2009 141 144
222. M. Koga, S. Matsumoto, H. Saito, and S. Kasayama Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients Endocr. J. 53 2006 387 391 (Pubitemid 43988169)
223. R. Nishimura, A. Kanda, H. Sano, T. Matsudaira, Y. Miyashita, A. Morimoto, T. Shirasawa, T. Kawaguchi, and N. Tajima Glycated albumin is low in obese, non-diabetic children Diabet. Res. Clin. Pract. 71 2006 334 338
224. P. Goldwasser, and J. Feldman Association of serum albumin and mortality risk J. Clin. Epidemiol. 50 1997 693 703 (Pubitemid 27341819)
225. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685